Additional file 1 of Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatmentLink copied to clipboard!
-
- Description:
- Additional file 1: Supplementary Table S1, Supplementary Table S2, Supplementary Table S3, and Supplementary Table S4. Supplementary Table S1. Shows an overview of the Breast Cancer Association Consortium studies included in the analyses. Supplementary Table S2. Includes the rationale and references to the literature supporting the choice of each subgroup for inclusion in a genome-wide association study on breast cancer-specific survival. Supplementary Table S3. Shows the characteristics of the breast cancer patients included in the 15-year breast cancer-specific survival analyses, overall and by subgroup. Supplementary Table S4. Shows the characteristics of the breast cancer patients included in the 5-year breast cancer-specific survival analyses for subgroups defined based on type of systemic treatment received.
-
- Author(s):
- Morra, Anna, Escala-Garcia, MariaAntoni van Leeuwenhoek Hospital, Beesley, JonathanAntoni van Leeuwenhoek Hospital, Keeman, RenskeQIMR Berghofer Medical Research Institute, Canisius, SanderAntoni van Leeuwenhoek Hospital, Ahearn, Thomas U., Andrulis, Irene L.Antoni van Leeuwenhoek Hospital, Anton-Culver, HodaUniversity of Toronto Lunenfeld-Tanenbaum Research Institute, Arndt, VolkerUniversity of California, Irvine, Auer, Paul L.German Cancer Research Center, Augustinsson, AnnelieFred Hutchinson Cancer Center University of Wisconsin–Milwaukee, Beane Freeman, Laura E.Lund University, Becher, HeikoNational Cancer Institute, Beckmann, Matthias W.University Medical Center Hamburg-Eppendorf, Behrens, SabineUniversitätsklinikum Erlangen, Bojesen, Stig E., Bolla, Manjeet K.German Cancer Research Center, Brenner, HermannUniversity of Cambridge, Brüning, ThomasGerman Cancer Research Center, Buys, Saundra S.Ruhr University Bochum, Caan, BetteHuntsman Cancer Institute, Campa, DanieleKaiser Permanente, Canzian, FedericoGerman Cancer Research Center University of Pisa, Castelao, Jose E., Chang-Claude, JennyGerman Cancer Research Center, Chanock, Stephen J.German Cancer Research Center University Cancer Center Hamburg, Cheng, Ting-Yuan DavidNational Cancer Institute, Clarke, Christine L.Roswell Park Comprehensive Cancer Center, Colonna, Sarah V.The University of Sydney, Couch, Fergus J.Huntsman Cancer Institute, Cox, AngelaMayo Clinic, Cross, Simon S.University of Sheffield, Czene, KamilaUniversity of Sheffield, Daly, Mary B.Karolinska Institute, Dennis, JoeFox Chase Cancer Center, Dörk, ThiloUniversity of Cambridge, Dossus, LaureHannover Medical School, Dunning, Alison M.International Agency for Research on Cancer, Dwek, MiriamUniversity of Cambridge, Eccles, Diana M.University of Westminster, Ekici, Arif B.University of Southampton, Eliassen, A. HeatherUniversitätsklinikum Erlangen, Eriksson, MikaelHarvard University, Evans, D. GarethKarolinska Institute, Fasching, Peter A.University of Manchester St Mary's Hospital, Flyger, HenrikUniversity of California, Los Angeles Universitätsklinikum Erlangen, Fritschi, LinCopenhagen University Hospital, Gago-Dominguez, Manuela, García-Sáenz, José A.Curtin University, Giles, Graham G.Hospital Clínico San Carlos, Grip, MerviMonash University University of Melbourne Cancer Council Victoria, Guénel, PascalUniversity of Oulu, Gündert, MelanieInserm, Hahnen, EricHeidelberg University German Cancer Research Center Helmholtz Zentrum München, Haiman, Christopher A.University of Cologne, Håkansson, NiclasUniversity of Southern California, Hall, PerKarolinska Institute, Hamann, UteKarolinska Institute Stockholm South General Hospital, Hart, Steven N.German Cancer Research Center, Hartikainen, Jaana M.Mayo Clinic, Hartmann, ArndtUniversity of Eastern Finland, He, WeiUniversitätsklinikum Erlangen, Hooning, Maartje J.Karolinska Institute, Hoppe, ReinerErasmus MC Cancer Institute, Hopper, John L.University of Tübingen Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Howell, AnthonyUniversity of Melbourne, Hunter, David J.University of Manchester, Jager, AgnesUniversity of Oxford Harvard University, Jakubowska, AnnaErasmus MC Cancer Institute, Janni, WolfgangPomeranian Medical University, John, Esther M.University Hospital Ulm, Jung, Audrey Y.Stanford University, Kaaks, RudolfGerman Cancer Research Center, Keupers, MachteldGerman Cancer Research Center, Kitahara, Cari M.KU Leuven, Koutros, StellaNational Cancer Institute, Kraft, PeterNational Cancer Institute, Kristensen, Vessela N.Harvard University, Kurian, Allison W.Oslo University Hospital University of Oslo, Lacey, James V.Stanford University, Lambrechts, Diether, Le Marchand, LoicCity Of Hope National Medical Center, Lindblom, AnnikaUniversity of Hawaii at Manoa, Linet, MarthaKarolinska University Hospital Karolinska Institute, Luben, Robert N.National Cancer Institute, Lubiński, JanUniversity of Cambridge, Lush, MichaelPomeranian Medical University, Mannermaa, ArtoUniversity of Cambridge, Manoochehri, MehdiUniversity of Eastern Finland Kuopio University Hospital, Margolin, SaraGerman Cancer Research Center, Martens, John W. M.Karolinska Institute Stockholm South General Hospital, Martinez, Maria ElenaErasmus MC Cancer Institute, Mavroudis, DimitriosUniversity of California, San Diego, Michailidou, KyriakiUniversity Hospital of Heraklion, Milne, Roger L.University of Cambridge Cyprus Institute of Neurology and Genetics, Mulligan, Anna MarieMonash University University of Melbourne Cancer Council Victoria, Muranen, Taru A.University of Toronto University Health Network, Nevanlinna, HeliUniversity of Helsinki, Newman, William G.University of Helsinki, Nielsen, Sune F., Nordestgaard, Børge G., Olshan, Andrew F.University of Manchester St Mary's Hospital, Olsson, HåkanUniversity of North Carolina at Chapel Hill, Orr, NickLund University, Park-Simon, Tjoung-WonQueen's University Belfast, Patel, Alpa V.Hannover Medical School, Peissel, BernardAmerican Cancer Society, Peterlongo, PaoloFondazione IRCCS Istituto Nazionale dei Tumori, Plaseska-Karanfilska, Dijana, Prajzendanc, KarolinaFIRC Institute of Molecular Oncology, Prentice, RossPomeranian Medical University, Presneau, NadegeFred Hutchinson Cancer Center, Rack, BrigitteUniversity of Westminster, Rennert, GadUniversity Hospital Ulm, Rennert, Hedy S.Carmel Medical Center, Rhenius, ValerieCarmel Medical Center, Romero, AtochaUniversity of Cambridge, Roylance, RebeccaHospital Universitario Puerta de Hierro Majadahonda, Ruebner, MatthiasUniversity College London Hospitals NHS Foundation Trust, Saloustros, EmmanouilUniversitätsklinikum Erlangen, Sawyer, Elinor J.University Hospital of Larissa, Schmutzler, Rita K.King's College London, Schneeweiss, AndreasUniversity of Cologne, Scott, ChristopherHeidelberg University National Center for Tumor Diseases, Shah, MitulMayo Clinic, Smichkoska, SnezhanaUniversity of Cambridge, Southey, Melissa C.Saints Cyril and Methodius University of Skopje, Stone, JenniferMonash University University of Melbourne Cancer Council Victoria, Surowy, HaraldUniversity of Melbourne University of Western Australia, Swerdlow, Anthony J.Heidelberg University German Cancer Research Center, Tamimi, Rulla M.Institute of Cancer Research, Tapper, William J.Cornell University Harvard University, Teras, Lauren R.University of Southampton, Terry, Mary BethAmerican Cancer Society, Tollenaar, Rob A. E. M.Columbia University, Tomlinson, IanLeiden University Medical Center, Troester, Melissa A.University of Birmingham University of Oxford, Truong, ThérèseUniversity of North Carolina at Chapel Hill, Vachon, Celine M.Inserm, Wang, QinMayo Clinic, Hurson, Amber N.University of Cambridge, Winqvist, RobertNational Cancer Institute, Wolk, AlicjaUniversity of Oulu NordLab, Ziogas, ArgyriosUppsala University Karolinska Institute, Brauch, HiltrudUniversity of California, Irvine, García-Closas, MontserratUniversity of Tübingen Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Pharoah, Paul D. P.National Cancer Institute, Easton, Douglas F.University of Cambridge, Chenevix-Trench, GeorgiaUniversity of Cambridge, and Schmidt, Marjanka K.QIMR Berghofer Medical Research Institute
-
- Source Repository:
- Figshare
- Publisher(s):
- figshare
-
- License:
- Creative Commons Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/legalcode
-
- URL:
- https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Association_of_germline_genetic_variants_with_breast_cancer-specific_survival_in_patient_subgroups_defined_by_clinic-pathological_variables_related_to_tumor_biology_and_type_of_systemic_treatment/15253977
-
- Publication date:
- 2021
-
- Subjects:
-
- Identifier:
- https://doi.org/10.6084/m9.figshare.15253977
Geospatial information
There is no geographic information available for this record.
Select geospatial feature(s) to view on map:
Citation
-
- APA Citation:
-
Morra, A., Escala-Garcia, M., Beesley, J., Keeman, R., Canisius, S., Ahearn, T. U., Andrulis, I. L., Anton-Culver, H., Arndt, V., Auer, P. L., Augustinsson, A., Beane Freeman, L. E., Becher, H., Beckmann, M. W., Behrens, S., Bojesen, S. E., Bolla, M. K., Brenner, H., Brüning, T., … Schmidt, M. K. (2021). Additional file 1 of Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment [Data set]. Figshare. https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Association_of_germline_genetic_variants_with_breast_cancer-specific_survival_in_patient_subgroups_defined_by_clinic-pathological_variables_related_to_tumor_biology_and_type_of_systemic_treatment/15253977Citation copied to clipboard
-
- Export to citation manager:
-